Literature DB >> 10199886

Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism.

P Kessler1, R Popp, R Busse, V B Schini-Kerth.   

Abstract

BACKGROUND: Endothelium-dependent dilator responses mediated by NO and endothelium-derived hyperpolarizing factor (EDHF) are altered in arteriosclerosis and sepsis. The possibility that proinflammatory mediators that stimulate the expression of inducible NO synthase (NOS II) affect the generation of EDHF was examined in isolated arteries. METHODS AND
RESULTS: Under combined blockade of NOS and cyclooxygenase, EDHF-mediated relaxation elicited by several agonists was significantly attenuated in rabbit carotid and porcine coronary arteries exposed to cytokines and lipopolysaccharide. The blunted relaxation was coincident with NOS II expression and was prevented by inhibition of NOS II as well as of global protein synthesis. The NO donor CAS 1609 and 8-bromo-cGMP mimicked the proinflammatory mediator effect. In contrast, long-term blockade of endothelial NO generation increased the relaxation in carotid but not in coronary arteries. Proinflammatory mediators reduced the synthesis of EDHF assessed as hyperpolarization of vascular smooth muscle cells elicited by the effluent from bradykinin-stimulated coronary arteries. Proinflammatory mediators induced NOS II expression in cultured endothelial cells and decreased the expression of cytochrome P450 enzymes, which are the most probable candidates for the synthesis of EDHF.
CONCLUSIONS: Proinflammatory mediators inhibit the formation of EDHF in isolated arteries. This impairment is coincident with NOS II expression in the arterial wall and seems to be mediated through the induced generation of NO, which downregulates the putative EDHF-forming enzyme. Thus, a decreased formation of EDHF may contribute to the endothelial dysfunction in arteriosclerosis and sepsis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199886     DOI: 10.1161/01.cir.99.14.1878

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

2.  Endothelial dysfunction in patients with primary Sjögren's syndrome.

Authors:  Timur Pirildar; Canan Tikiz; Sabriye Ozkaya; Serdar Tarhan; Ozan Utük; Hakan Tikiz; Uğur Kemal Tezcan
Journal:  Rheumatol Int       Date:  2005-06-17       Impact factor: 2.631

3.  TNF-α impairs endothelial function in adipose tissue resistance arteries of mice with diet-induced obesity.

Authors:  Anthony J Donato; Grant D Henson; R Garrett Morgan; Ryley A Enz; Ashley E Walker; Lisa A Lesniewski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-20       Impact factor: 4.733

Review 4.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

5.  Potassium inhibits nitric oxide and adenosine arteriolar vasodilatation via K(IR) and Na(+)/K(+) ATPase: implications for redundancy in active hyperaemia.

Authors:  Iain R Lamb; Coral L Murrant
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

6.  Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy.

Authors:  Anusha Mishra; Eric A Newman
Journal:  Glia       Date:  2010-12       Impact factor: 7.452

7.  5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation.

Authors:  Bahar Tunctan; Belma Korkmaz; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; Mehmet Sami Serin; C Kemal Buharalioglu; Seyhan Sahan-Firat; Tuba Cuez; Wolf-Hagen Schunck; John R Falck; Kafait U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-02-27       Impact factor: 3.072

Review 8.  Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.

Authors:  William B Campbell; Kathryn M Gauthier
Journal:  J Cardiovasc Pharmacol       Date:  2013-03       Impact factor: 3.105

9.  Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.

Authors:  G Vaudo; S Marchesi; R Gerli; R Allegrucci; A Giordano; D Siepi; M Pirro; Y Shoenfeld; G Schillaci; E Mannarino
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

10.  Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.

Authors:  Bahar Tunctan; Belma Korkmaz; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; Mehmet Sami Serin; C Kemal Buharalioglu; Seyhan Sahan-Firat; Tuba Cuez; Wolf-Hagen Schunck; Vijaya L Manthati; John R Falck; Kafait U Malik
Journal:  Nitric Oxide       Date:  2013-05-14       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.